Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 53005-44-0 | MDL No. : | MFCD10699539 |
Formula : | C9H9NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZZZIUEZLZGDVBG-UHFFFAOYSA-N |
M.W : | 147.17 | Pubchem ID : | 590226 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 42.62 |
TPSA : | 33.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.79 cm/s |
Log Po/w (iLOGP) : | 2.06 |
Log Po/w (XLOGP3) : | 1.98 |
Log Po/w (WLOGP) : | 1.88 |
Log Po/w (MLOGP) : | 1.44 |
Log Po/w (SILICOS-IT) : | 2.26 |
Consensus Log Po/w : | 1.92 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.34 |
Solubility : | 0.677 mg/ml ; 0.0046 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.3 |
Solubility : | 0.739 mg/ml ; 0.00502 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.98 |
Solubility : | 0.155 mg/ml ; 0.00105 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.39 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 15 h; | To intermediate 144 (7.50 g, 45.41 mmol) in dichloromethane (55 ml), Ν,Ν'-dicarbonyl diimidazole (8.09 g, 49.95 mmol) was added and stirred at room temperature for 15h. The reaction mass was quenched with water, extracted with dichloromethane, dried over sodium sulphate and concentrated to afford the title compound as brown solid (5.0 g , 75percent). -NMR (δ ppm, CDCI3, 400 MHz): 7.41 (t, J = 8.1 Hz, 1 H), 6.87 (d, J = 7.7 Hz, 1 H), 6.78 (d, J = 8.5 Hz, 1 H), 3.91 (s, 3H), 2.50 (s, 3H). |
75% | With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 15 h; | Intermediate 145 2-methoxy-6-methylbenzonitrile: To intermediate 144 (7.50 g, 45.41 mmol) in dichloromethane (55 ml), N,N'-dicarbonyl diimidazole (8.09 g, 49.95 mmol) was added and stirred at room temperature for 15 h. The reaction mass was quenched with water, extracted with dichloromethane, dried over sodium sulphate and concentrated to afford the title compound as brown solid (5.0 g, 75percent). 1H-NMR (δ ppm, CDCl3, 400 MHz): 7.41 (t, J=8.1 Hz, 1H), 6.87 (d, J=7.7 Hz, 1H), 6.78 (d, J=8.5 Hz, 1H), 3.91 (s, 3H), 2.50 (s, 3H). |
[ 152775-45-6 ]
4-Methoxy-3,5-dimethylbenzonitrile
Similarity: 0.95
[ 39835-11-5 ]
2-Hydroxy-4-methoxybenzonitrile
Similarity: 0.95
[ 152775-45-6 ]
4-Methoxy-3,5-dimethylbenzonitrile
Similarity: 0.95
[ 39835-11-5 ]
2-Hydroxy-4-methoxybenzonitrile
Similarity: 0.95
[ 152775-45-6 ]
4-Methoxy-3,5-dimethylbenzonitrile
Similarity: 0.95
[ 39835-11-5 ]
2-Hydroxy-4-methoxybenzonitrile
Similarity: 0.95